Correlation Between Edgewise Therapeutics and Larimar Therapeutics

Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Larimar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Larimar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Edgewise Therapeutics and Larimar Therapeutics, you can compare the effects of market volatilities on Edgewise Therapeutics and Larimar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Larimar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Larimar Therapeutics.

Diversification Opportunities for Edgewise Therapeutics and Larimar Therapeutics

0.71

Correlation Coefficient

Edgewise Therapeutics  Larimar Therapeutics

Poor diversification

The 3 months correlation between Edgewise and Larimar is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Larimar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Larimar Therapeutics and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Larimar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Larimar Therapeutics has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Larimar Therapeutics go up and down completely randomly.

Pair Corralation between Edgewise Therapeutics and Larimar Therapeutics

Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 0.66 times more return on investment than Larimar Therapeutics. However, Edgewise Therapeutics is 1.51 times less risky than Larimar Therapeutics. It trades about -0.13 of its potential returns per unit of risk. Larimar Therapeutics is currently generating about -0.19 per unit of risk. If you would invest  3,594  in Edgewise Therapeutics on October 6, 2024 and sell it today you would lose (822.00) from holding Edgewise Therapeutics or give up 22.87% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Edgewise Therapeutics  vs.  Larimar Therapeutics

Edgewise Therapeutics

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Edgewise Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Edgewise Therapeutics is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Larimar Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Larimar Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's primary indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Edgewise Therapeutics and Larimar Therapeutics

The main advantage of trading using opposite Edgewise Therapeutics and Larimar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Larimar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Larimar Therapeutics will offset losses from the drop in Larimar Therapeutics' long position.

The idea behind Edgewise Therapeutics and Larimar Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.